Stora Enso Oyj (0KCK)
London Exchange · UK · prices in SEK · close of 22 Oct 2026
Key indicators
| Last close | SEK 106.95 |
|---|---|
| 52-week range | 95.75 – 127.50 |
| Return, 1 month / 3 months | −10.5% / −2.6% |
| Return, 1 year / 3 years | +13.8% / −9.2% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 29.5% |
| Worst drawdown (1 year) | -20.7% |
| Average daily value traded | 1.38M SEK |
| Dividend yield | 28.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Stora Enso is a forest products company based in Helsinki, Finland. It makes renewable materials from wood and biomass, including packaging boards and cartons, paper for printing and writing, and sawn timber and wood products for construction. Its customers are packaging converters, publishers, printers, builders and industrial manufacturers across Europe and other markets. The company also manages forests and provides wood supply services, positioning itself around fibre-based materials that replace fossil-based alternatives in everyday products.
On this site Stora Enso Oyj appears as a stock on the London Exchange (UK), code 0KCK, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Stora Enso Oyj (0KCK) trades on the London Exchange in UK. It last closed at SEK 106.95 on 22 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,427 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.8% and over the last three months it fell 2.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.6% | ||
| From 52-week high | -15.4% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.6% | ||
| 6-month return | -2.5% | ||
| 12-month return, skipping the last month | 27.1% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.7% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.38M SEK | ||
| Zero-volume days | 13.3% | ||
| Income | 70 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 28.7% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −4.0% |
|---|---|
| 1 month | −10.5% |
| 3 months | −2.6% |
| 6 months | −2.5% |
| 1 year | +13.8% |
| 3 years | −9.2% |
| 5 years | −14.5% |
Signals
| 50-day / 200-day average | 111.97 / 108.65 |
|---|---|
| Golden / death cross (60 days) | Golden, 23 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.75 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Sep 2026 | EUR 1.3549 |
| 25 Mar 2026 | EUR 1.4041 |
| 24 Sep 2025 | EUR 1.3234 |
| 21 Mar 2025 | EUR 1.4317 |
| 12 Dec 2024 | EUR 1.1519 |
| 21 Mar 2024 | EUR 1.1371 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.